Budesonide Inhalation Aerosol Market Report: Trends, Forecast and Competitive Analysis to 2031
상품코드:1783468
리서치사:Lucintel
발행일:2025년 07월
페이지 정보:영문 150 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 부데소니드 흡입 에어로졸 시장 미래는 병원과 병원 시장에서의 기회에 유망시되고 있습니다. 세계의 부데소니드 흡입 에어로졸 시장은 2025-2031년 연평균 복합 성장률(CAGR) 7.0%를 나타낼 것으로 전망됩니다. 이 시장의 주요 촉진요인은 호흡기 질환의 유병률 증가, 흡입 요법 옵션 채용률 증가, 천식 및 COPD 치료에 대한 인식 증가입니다.
Lucintel사의 예측에서는 유형별로는 제네릭 의약품이 예측 기간 중에 높은 성장을 이룰 전망입니다.
용도별로는 병원이 높은 성장이 예상됩니다.
지역별로는 APAC이 예측 기간 동안 가장 높은 성장이 예상됩니다.
150페이지 이상의 종합적인 보고서를 통해 비즈니스 의사 결정에 도움이 되는 귀중한 인사이트를 제공합니다. 몇 가지 인사이트를 포함하는 샘플 다이어그램이 아래에 나와 있습니다.
부데소니드 흡입 에어로졸 시장 새로운 동향
부데소니드 흡입 에어로졸 시장은 환자 결과 개선, 편의성 향상 및 치료 용도 확대를 목표로 많은 신흥 동향의 영향을 받고 있습니다. 이러한 추세는 흡입기 장치의 기술 진보, 호흡기 질환의 치료 패러다임의 변화, 개인화된 의료 전략의 중요성 증가에 의해 뒷받침됩니다.
스마트 흡입기 기술 : 스마트 기술을 부데소니드 흡입기에 통합함으로써 환자는 복용량, 사용 패턴 및 알림을 모니터링할 수 있습니다. 이러한 추세는 처방된 처방에 대한 환자의 컴플라이언스를 높이고 헬스케어 전문가에게 중요한 데이터를 제공하는 데 중점을 둡니다.
병용요법 : 부데소니드를 장시간 작용형 β작용제(LABA)와 합제로 한 흡입 에어로졸의 제제화가 점점 보급되어 사용량도 증가하고 있습니다. 이 전략은 항 염증 효과와 기관지 확장 효과를 모두 가져와 천식과 COPD에 대한보다 완전한 치료법입니다.
개인화된 의료 전략 : 호흡기 치료에서 개인화된 의료의 새로운 동향으로 부데소니드의 복용량과 투여 방법을 환자의 개성, 중증도, 치료 반응성에 따라 최적화하고 예후를 개선할 수 있습니다.
온실 친화적인 추진제 : 환경에 대한 압력이 증가하는 동안 하이드로 플루오로 알칸 HFA를 포함하여보다 환경 친화적인 추진제를 사용하여 부데소니드 흡입 에어로졸을 제조하는 것은 기존의 오래된 프론 흡입기에서 벗어나는 새로운 동향입니다.
원격 의료 및 원격 모니터링 : 원격 의료 및 원격 환자 모니터링 플랫폼이 상승하고 있으며 가상 진단, 원격 증상 추적, 컴플라이언스 모니터링을 가능하게 하고 환자 관리를 개선하여 부데소니드 흡입 에어로졸 시장에 영향을 미칩니다.
이러한 추세는 치료 효과를 극대화하고 환자의 편의성을 높이고 보다 광범위한 건강 관리의 디지털화 및 지속가능성 목표와 연동하여 부데소니드 흡입 에어로졸 시장을 변화시키고 있습니다. 스마트 흡입기, 병용 요법, 맞춤형 의료, 환경 친화적인 추진제, 원격 의료가 중시됨으로써 호흡기 질환의 관리·치료 방법에 변화가 일어나고 있습니다.
부데소니드 흡입 에어로졸 시장 최근 동향
부데소니드 흡입 에어로졸 시장에서는 치료 효과를 극대화하고 환자의 컴플라이언스를 향상시키고 호흡기 질환 관리에 대한 가용성을 높이기 위해 최근 몇 가지 개발이 이루어지고 있습니다. 이러한 개발은 만성 폐 질환으로 고통받는 사람들의 삶의 질을 개선하기 위한 지속적인 노력을 반영합니다.
배합제의 후발품 승인 부데소니드와 포르모테롤(장시간 작용형 β작용제)을 조합한 흡입 에어로졸의 후발품 승인으로 경쟁이 촉진되어 환자에게 필수적인 병용 요법이 보다 비용 효율적이 되었습니다.
스마트 흡입기 출시 : 디지털 플랫폼과 결합된 스마트 흡입기 개발은 획기적인 것으로, 환자와 임상의가 복용 어드히어런스를 추적하고 사용 패턴을 실시간으로 모니터링할 수 있습니다.
조기 치료에 사용 확대 : 부데소니드 흡입 에어로졸을 경증 천식의 조기 치료에 사용함으로써 질병의 진행을 막고 중증 악화를 예방하는 것이 임상 증거와 조사에 의해 점점 더 뒷받침되고 있습니다.
장치 기술의 진보 : 강화된 정량 흡입기 및 건식 분말 흡입기 등 보다 환자에게 부드럽고 효율적인 흡입 장치가 제조업체에 의해 개발되어, 약물을 최적으로 전달하여 모든 연령대의 환자가 쉽게 사용할 수 있도록 되어 있습니다.
COVID-19 관련 조사 : 팬데믹은 경도에서 중등도의 COVID-19 질환에 대한 부데소니드와 같은 흡입 코르티코스테로이드의 잠재적인 치료 효과에 대한 연구로 이어졌으며, 일시적으로 시장 동향과 연구 노력에 영향을 주었습니다.
이러한 중요한 진보는 병용 요법에 대한 접근, 스마트 기술을 통한 환자 컴플라이언스, 조기 개입 및 사용이 용이한 장치의 강화로 부데소니드 흡입 에어로졸 시장에 큰 영향을 미칩니다. 시장은 호흡기 관리의 지속적인 혁신으로 환자 중심, 경쟁 및 기술에 중점을 두고 있습니다.
목차
제1장 주요 요약
제2장 세계의 부데소니드 흡입 에어로졸 시장 : 시장 역학
서론, 배경, 분류
공급망
PESTLE 분석
특허 분석
규제 환경
업계의 성장 촉진요인과 과제
제3장 시장 동향과 예측 분석(2019-2031년)
거시 경제 동향(2019-2024년)과 예측(2025-2031년)
세계의 부데소니드 흡입 에어로졸 시장 동향(2019-2024년)과 예측(2025-2031년)
세계의 부데소니드 흡입 에어로졸 시장 : 유형별
오리지널 의약품 : 동향과 예측(2019-2031년)
제네릭 의약품 : 동향과 예측(2019-2031년)
세계의 부데소니드 흡입 에어로졸 시장 : 용도별
병원 : 동향과 예측(2019-2031년)
클리닉 : 동향과 예측(2019-2031년)
기타 : 동향과 예측(2019-2031년)
제4장 지역별 시장 동향과 예측 분석(2019-2031년)
세계의 부데소니드 흡입 에어로졸 시장 : 지역별
북미의 부데소니드 흡입 에어로졸 시장
유럽의 부데소니드 흡입 에어로졸 시장
아시아태평양의 부데소니드 흡입 에어로졸 시장
기타 지역의 부데소니드 흡입 에어로졸 시장
제5장 경쟁 분석
제품 포트폴리오 분석
운영 통합
Porter's Five Forces 분석
경쟁 기업 간 경쟁 관계
구매자의 협상력
공급기업의 협상력
대체품의 위협
신규 참가업체의 위협
제6장 성장 기회와 전략 분석
성장 기회 분석
세계의 부데소니드 흡입 에어로졸 시장 성장 기회 : 유형별
세계의 부데소니드 흡입 에어로졸 시장 성장 기회 : 용도별
세계의 부데소니드 흡입 에어로졸 시장 성장 기회 : 지역별
세계의 부데소니드 흡입 에어로졸 시장 새로운 동향
전략 분석
신제품 개발
세계의 부데소니드 흡입 에어로졸 시장 능력 확대
세계의 부데소니드 흡입 에어로졸 시장 합병, 인수, 합작 사업
인증 및 라이선싱
제7장 주요 기업의 기업 프로파일
Chiesi Farmaceutici
Shanghai Sine Promod Pharmaceutical
Lunan Better Pharmaceutical
Pfizer
KTH
영문 목차
영문목차
The future of the global budesonide inhalation aerosol market looks promising with opportunities in the hospital and clinic markets. The global budesonide inhalation aerosol market is expected to grow with a CAGR of 7.0% from 2025 to 2031. The major drivers for this market are the increasing prevalence of respiratory diseases, the rising adoption of inhalation therapy options, and the growing awareness of asthma and COPD treatments.
Lucintel forecasts that, within the type category, generic drug is expected to witness higher growth over the forecast period.
Within the application category, hospital is expected to witness higher growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.
Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.
Emerging Trends in the Budesonide Inhalation Aerosol Market
The budesonide inhalation aerosol market is influenced by a number of emerging trends that seek to enhance patient outcomes, increase convenience, and expand therapeutic uses. These trends are fueled by advances in technology in inhaler devices, shifting treatment paradigms for respiratory conditions, and an increasing emphasis on personalized medicine strategies.
Smart Inhaler Technology: Incorporating smart technology into budesonide inhalers, patients can monitor dosage, usage patterns, and reminders. Such a trend is focused on boosting patient compliance with the prescribed regimen and offering important data to healthcare professionals.
Combination Therapies: Increasingly popular is the formulation and growing use of budesonide in fixed-dose combination inhalation aerosols with long-acting beta-agonists (LABAs). This strategy provides a more complete therapy for asthma and COPD through the delivery of both anti-inflammatory and bronchodilator actions.
Personalized Medicine Strategies: There is a new trend towards personalized medicine in respiratory therapy, wherein budesonide dosage and mode of delivery are optimized according to patient individuality, severity of the condition, and therapeutic response, possibly improving outcomes.
Greenhouse-Friendly Propellants: With mounting environmental pressure, creating budesonide inhalation aerosols using more environmentally friendly propellants, including hydrofluoroalkanes HFA, is a new trend away from traditional older chlorofluorocarbon CFC inhalers.
Telemedicine and Remote Monitoring: Telemedicine and remote patient monitoring platforms have been on the rise, affecting the budesonide inhalation aerosol market by allowing virtual consultations, remote symptom tracking, and compliance monitoring, improving patient management.
These trends together are transforming the budesonide inhalation aerosol market by maximizing treatment effectiveness, increasing convenience for patients, and dovetailing with broader healthcare digitalization and sustainability objectives. The emphasis on smart inhalers, combination therapy, personalized medicine, environmentally friendly propellants, and telemedicine is revolutionizing how respiratory diseases are managed and treated.
Recent Developments in the Budesonide Inhalation Aerosol Market
The market for budesonide inhalation aerosol has witnessed some recent developments in an effort to maximize treatment effectiveness, enhance patient compliance, and increase its availability for the management of respiratory disorders. These developments reflect the ongoing efforts to improve the quality of life of those suffering from chronic lung diseases.
Generic Approvals for Combination Products: Generic approval of budesonide combined with formoterol (a long-acting beta-agonist) in the form of inhalation aerosols has promoted competition and rendered this essential combination therapy more cost-effective for patients.
Smart Inhaler Launches: Launch of smart inhaler devices coupled with digital platforms has been a landmark development, allowing patients and clinicians to track medication adherence and monitor usage patterns in real time.
Extended Use in Early Treatment: Clinical evidence and research are increasingly endorsing the application of budesonide inhalation aerosol for early treatment of mild asthma with a view to arresting disease progression and preventing severe exacerbations.
Advances in Device Technology: More patient-friendly and efficient inhalation devices, such as enhanced metered-dose inhalers and dry powder inhalers, are being developed by manufacturers to deliver drugs optimally and facilitate easy use by patients of all ages.
COVID-19 Related Research: The pandemic led to studies on the potential therapeutic effects of inhaled corticosteroids, such as budesonide, on mild-to-moderate COVID-19 illness, which temporarily affected market trends and research efforts.
These critical advancements are heavily influencing the market for budesonide inhalation aerosol by enhancing combination therapy access, patient compliance with smart technology, earlier intervention, and more user-friendly devices. The market is becoming patient-centric, competitive, and technology-focused due to ongoing innovation in respiratory care.
Strategic Growth Opportunities in the Budesonide Inhalation Aerosol Market
The budesonide inhalation aerosol market offers a number of strategic growth opportunities by targeting specific patient populations and maximizing treatment strategies for respiratory diseases. Tailoring initiatives to meet unmet needs and enhance patient outcomes can fuel market growth and support its value proposition.
Asthma Maintenance Therapy: Prioritizing budesonide inhalation aerosol as a cornerstone for long-term maintenance therapy in mild to severe asthma, highlighting its anti-inflammatory action to avoid exacerbations and enhance lung function.
Chronic Obstructive Pulmonary Disease COPD Management: Widening the role of budesonide, especially in association with LABAs, for COPD management, particularly in frequent exacerbators or those with an asthmatic component.
Pediatric Asthma Management: Emphasizing budesonide inhalation aerosol as a safe and effective agent for the management of pediatric asthma, taking advantage of its good safety profile and existence in multiple strengths and delivery devices appropriate for children.
Emergency Department and Urgent Care Settings: Encouraging the administration of budesonide in acute asthma or COPD exacerbations in emergency and urgent care settings to rapidly alleviate inflammation and improve respiratory function, minimizing the use of systemic corticosteroids.
Targeting Treatment-Resistant Asthma: Examining and finding ways to employ higher doses or combination therapy with budesonide in severe or treatment-resistant asthma patients for improved symptom control and decreased disease burden.
These strategic growth opportunities by indication are influencing the budesonide inhalation aerosol market by broadening its therapeutic scope and targeting particular patient needs throughout the range of respiratory disorders. Focusing on asthma maintenance, COPD management, pediatric application, acute treatment, and treatment-resistant conditions is propelling innovation and market growth.
Budesonide Inhalation Aerosol Market Driver and Challenges
The market for budesonide inhalation aerosol is driven by an intricate mix of factors that function as both compelling drivers of growth for it as well as consequential challenges affecting its universal adoption. These factors involve the increasing occurrence of respiratory illness, advances in technology, regulatory barriers, and economic factors.
The factors responsible for driving the budesonide inhalation aerosol market include:
1. Growing Incidence of Respiratory Disorders: One of the major drivers is the worldwide increase in the incidence and prevalence of chronic respiratory disorders such as asthma and COPD, leading to a steady demand for effective inhaled corticosteroids like budesonide.
2. Anti-inflammatory Efficacy: Budesonide's proven efficacy as a powerful inhaled corticosteroid in lowering airway inflammation, averting exacerbations, and enhancing lung function is one of the major drivers for its extensive use in respiratory disorders.
3. Advances in Inhaler Technology: Ongoing technological advances in inhaler device technology, resulting in increased drug delivery efficiency, greater patient compliance, and greater ease of use, drive market growth considerably.
4. Increased Geriatric Population: The global geriatric population's growth increases its vulnerability to chronic respiratory illnesses, which enhances demand for budesonide inhalation aerosols for the long-term management of their illnesses.
5. Supportive Clinical Guidelines: Most prominent clinical guidelines by respiratory societies and health organizations endorse inhaled corticosteroids as a backbone of asthma and COPD care, further propelling the use of budesonide.
Challenges in the budesonide inhalation aerosol market are:
1. Treatment Adherence: In spite of advances in inhaler technology, inadequate patient compliance with daily maintenance therapy remains a key challenge, resulting in inferior disease control and elevated healthcare costs.
2. Side Effect Profile: Although well-tolerated overall, concerns regarding possible local side effects like oral thrush, dysphonia, and systemic effects at elevated doses can affect patient compliance and physician prescribing behavior.
3. Competition from Newer Therapies: The market is increasingly challenged by newer biologics and other advanced therapies for severe asthma and COPD, which can provide alternative treatment options for certain patient segments.
The key drivers of growing prevalence of respiratory disease, established efficacy, inhaled therapy advances in inhalers, expanding geriatric population, and favorable guidelines are driving the budesonide inhalation aerosol market. Yet patient compliance issues, possible side effects, and emerging therapy competition mandate continued efforts at patient education, product innovation, and strategic marketing to achieve steady growth and maximum patient benefits.
List of Budesonide Inhalation Aerosol Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies budesonide inhalation aerosol companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the budesonide inhalation aerosol companies profiled in this report include-
Chiesi Farmaceutici
Shanghai Sine Promod Pharmaceutical
Lunan Better Pharmaceutical
Pfizer
Budesonide Inhalation Aerosol Market by Segment
The study includes a forecast for the global budesonide inhalation aerosol market by type, application, and region.
Budesonide Inhalation Aerosol Market by Type [Value from 2019 to 2031]:
Original Drug
Generic Drug
Budesonide Inhalation Aerosol Market by Application [Value from 2019 to 2031]:
Hospital
Clinic
Others
Budesonide Inhalation Aerosol Market by Region [Value from 2019 to 2031]:
North America
Europe
Asia Pacific
The Rest of the World
Country Wise Outlook for the Budesonide Inhalation Aerosol Market
The market for budesonide inhalation aerosol is witnessing dynamic growth as a result of the growing incidence of respiratory disorders such as asthma and COPD. New developments are directed towards innovation in device technology to improve drug delivery, launch generic versions for enhanced affordability, and growth in combination therapies. Regulatory clearances and increased focus on patient compliance are also major drivers influencing this market worldwide.
United States: The US market for budesonide inhalation aerosol is marked by a large number of respiratory conditions and advanced healthcare infrastructure. Some recent trends witnessed have been the approval of generic forms of combination products, boosting patient access and competition. Improved adherence and data tracking have also been an ongoing theme in smart inhaler technology.
China: The market for China's budesonide inhalation aerosol is fast growing due to increasing air pollution and a huge patient base. Recent events include local players investing in sophisticated inhaler devices and raising generic budesonide products' production to address increasing demand and enhance affordability in the country.
Germany: The market for budesonide inhalation aerosol in Germany is focused on delivering high-quality and effective drug delivery. New trends include the significant focus on adherence programs and incorporating digital platforms to aid chronic respiratory disease patients. Research continues into maximizing treatment regimens for asthma and COPD.
India: India's market for budesonide inhalation aerosol is fueled by the rising incidence of respiratory diseases and the demand for low-cost treatment. Developments in the recent past include the aggressive launch of generic forms of budesonide by local players, bringing this critical medication within reach of more people.
Japan: Japan's budesonide inhalation aerosol market prioritizes patient safety and effective symptom control. Recent developments include the development of highly precise inhaler devices and the adoption of budesonide in combination therapies for improved management of asthma and COPD. Patient education and adherence programs are also significant.
Features of the Global Budesonide Inhalation Aerosol Market
Market Size Estimates: Budesonide inhalation aerosol market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Budesonide inhalation aerosol market size by type, application, and region in terms of value ($B).
Regional Analysis: Budesonide inhalation aerosol market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the budesonide inhalation aerosol market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the budesonide inhalation aerosol market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the budesonide inhalation aerosol market by type (original drug and generic drug), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Global Budesonide Inhalation Aerosol Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: PESTLE Analysis
2.4: Patent Analysis
2.5: Regulatory Environment
2.6: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2019 to 2031
3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
3.2. Global Budesonide Inhalation Aerosol Market Trends (2019-2024) and Forecast (2025-2031)
3.3: Global Budesonide Inhalation Aerosol Market by Type
3.3.1: Original Drug: Trends and Forecast (2019 to 2031)
3.3.2: Generic Drug: Trends and Forecast (2019 to 2031)
3.4: Global Budesonide Inhalation Aerosol Market by Application
3.4.1: Hospital: Trends and Forecast (2019 to 2031)
3.4.2: Clinic: Trends and Forecast (2019 to 2031)
3.4.3: Others: Trends and Forecast (2019 to 2031)
4. Market Trends and Forecast Analysis by Region from 2019 to 2031
4.1: Global Budesonide Inhalation Aerosol Market by Region
4.2: North American Budesonide Inhalation Aerosol Market
4.2.1: North American Market by Type: Original Drug and Generic Drug
4.2.2: North American Market by Application: Hospital, Clinic, and Others
4.2.3: The United States Budesonide Inhalation Aerosol Market
